Quick Answer
HARVARD BIOSCIENCE INC reported R&D Expense of $8.82 million for fiscal year 2025.
HARVARD BIOSCIENCE INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $8.82M | -15.2% |
| 2024 | $10.41M | -11.5% |
| 2023 | $11.76M | -4.6% |
| 2022 | $12.33M | +14.2% |
| 2021 | $10.80M | +24.3% |
| 2020 | $8.69M | -18.9% |
| 2019 | $10.71M | -2.5% |
| 2018 | $10.99M | +94.7% |
| 2017 | $5.64M | +4.7% |
| 2016 | $5.39M | -16.0% |
| 2015 | $6.42M | +31.6% |
| 2014 | $4.88M | +17.5% |
| 2013 | $4.15M | -4.4% |
| 2012 | $4.34M | +12.1% |
| 2011 | $3.87M | -17.0% |
| 2010 | $4.67M | +6.2% |
| 2009 | $4.40M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.13M | -16.9% | -2.6% |
| June 30, 2025 | $2.19M | -16.6% | -5.7% |
| March 31, 2025 | $2.32M | -19.5% | -9.6% |
| September 30, 2024 | $2.57M | -7.0% | -2.2% |
| June 30, 2024 | $2.63M | -11.2% | -9.0% |
| March 31, 2024 | $2.88M | -0.4% | +4.5% |
| September 30, 2023 | $2.76M | -0.1% | -6.7% |
| June 30, 2023 | $2.96M | -15.4% | +2.1% |
- HARVARD BIOSCIENCE INC showed a decrease of -15.2% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, HARVARD BIOSCIENCE INC’s r&d expense has grown by 100.8% (from $4.40 million to $8.82 million).
- The most recent figure is from HARVARD BIOSCIENCE INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: